BioVie Inc.BIVINASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank85
3Y CAGR-17.0%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-17.0%/yr
vs +74.0%/yr prior
Acceleration
-91.0pp
Decelerating
Percentile
P85
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$6.61M-22.9%
2025$8.57M-
2024$0.00-100.0%
2023$11.55M-
2022$0.00-
2021$0.00-
2020$0.00-100.0%
2019$1.26M-28.9%
2018$1.77M+106.5%
2017$857883.00-